Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso.
Rouamba T, Sondo P, Yerbanga IW, Compaore A, Traore-Coulibaly M, Hien FS, Diande NA, Valia D, Valea I, Akweongo P, Baiden R, Binka F, Kirakoya-Samadoulougou F, Tinto H. Rouamba T, et al. Among authors: binka f. Patient Prefer Adherence. 2019 Feb 28;13:371-380. doi: 10.2147/PPA.S190927. eCollection 2019. Patient Prefer Adherence. 2019. PMID: 30880921 Free PMC article.
The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso.
Tinto H, Valea I, Sorgho H, Tahita MC, Traore M, Bihoun B, Guiraud I, Kpoda H, Rouamba J, Ouédraogo S, Lompo P, Yara S, Kabore W, Ouédraogo JB, Guiguemdé RT, Binka FN, Ogutu B. Tinto H, et al. Malar J. 2014 Mar 22;13:113. doi: 10.1186/1475-2875-13-113. Malar J. 2014. PMID: 24655351 Free PMC article.
Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania.
Baiden R, Oduro A, Halidou T, Gyapong M, Sie A, Macete E, Abdulla S, Owusu-Agyei S, Mulokozi A, Adjei A, Sevene E, Compaoré G, Valea I, Osei I, Yawson A, Adjuik M, Akparibo R, Ogutu B, Upunda GL, Smith P, Binka F. Baiden R, et al. Among authors: binka f. Malar J. 2015 Apr 15;14:160. doi: 10.1186/s12936-015-0664-9. Malar J. 2015. PMID: 25885858 Free PMC article.
Feasibility and cost of using mobile phones for capturing drug safety information in peri-urban settlement in Ghana: a prospective cohort study of patients with uncomplicated malaria.
Kukula VA, Dodoo AA, Akpakli J, Narh-Bana SA, Clerk C, Adjei A, Awini E, Manye S, Nagai RA, Odonkor G, Nikoi C, Adjuik M, Akweongo P, Baiden R, Ogutu B, Binka F, Gyapong M. Kukula VA, et al. Among authors: binka f. Malar J. 2015 Oct 19;14:411. doi: 10.1186/s12936-015-0932-8. Malar J. 2015. PMID: 26481106 Free PMC article.
Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries.
Adjei A, Narh-Bana S, Amu A, Kukula V, Nagai RA, Owusu-Agyei S, Oduro A, Macete E, Abdulla S, Halidou T, Sie A, Osei I, Sevene E, Asante KP, Mulokozi A, Compaore G, Valea I, Adjuik M, Baiden R, Ogutu B, Binka F, Gyapong M. Adjei A, et al. Among authors: binka f. Malar J. 2016 Jan 27;15:43. doi: 10.1186/s12936-016-1099-7. Malar J. 2016. PMID: 26818128 Free PMC article.
Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms.
Kabanywanyi AM, Baiden R, Ali AM, Mahende MK, Ogutu BR, Oduro A, Tinto H, Gyapong M, Sie A, Sevene E, Macete E, Owusu-Agyei S, Adjei A, Compaoré G, Valea I, Osei I, Yawson A, Adjuik M, Akparibo R, Kakolwa MA, Abdulla S, Binka F. Kabanywanyi AM, et al. Among authors: binka f. PLoS One. 2016 Oct 20;11(10):e0164851. doi: 10.1371/journal.pone.0164851. eCollection 2016. PLoS One. 2016. PMID: 27764178 Free PMC article.
170 results